Drugs / MVA/HIV62B
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01571960 | Apr 2012 → Aug 2014 | HIV infectious disease | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MVA/HIV62B | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01571960 ↗ |
| Known as | MVA62B | “MVA/HIV62B (MVA62B) vaccine” NCT01571960 ↗ |
| Modality | Vaccine | “MVA/HIV62B (MVA62B) vaccine” NCT01571960 ↗ |
| Route | Intramuscular | “administered as a 1-mL IM injection into the deltoid” NCT01571960 ↗ |